Barclays Reviews McCormick (MKC) as ERP and Tax Pressures Come Into Focus
On January 26, Barclays analyst Andrew Lazar trimmed his price objective on McCormick & Company, Incorporated (NYSE:MKC) to $67 from $72.
Mccormick & Co Inc (MKC)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Impax Asset Management Ian Simm | 475,770 | $32,404,695 | -4% | 0.2% |
| 2. | Savoir Faire Capital Management Brian M. Crombie | 60,904 | $4,148,171 | -49% | 1.97% |
| 3. | Stevens Capital Management Matthew Tewksbury | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $99.62 | 2,500 | $249,050.00 | 2,500 | 2017-05-03 | Filing | |
| $71.77 | 1,000 | $71,770.00 | 1,310 | 2014-06-30 | Filing | |
| $64.40 | 310 | $19,963.38 | 310 | 2014-01-31 | Filing | |
| $29.30 | 2,500 | $73,250.00 | 2,500 | 2009-04-03 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $67.43 | 50,000 | $3,371,500.00 | 246,762 | 2026-01-13 | Filing | |
| $65.56 | 57,144 | $3,746,360.64 | 108,652 | 2025-11-12 | Filing | |
| $64.54 | 14,060 | $907,432.40 | 0 | 2025-11-11 | Filing | |
| $64.54 | 5,903 | $380,979.62 | 0 | 2025-11-11 | Filing | |
| $64.54 | 5,903 | $380,979.62 | 0 | 2025-11-11 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 32,679,906 | $2,225,828,397 | 0.03% | |
| 2. | 1,888,624 | $128,634,181 | 0.02% | |
| 3. | 1,306,700 | $88,986,270 | 0.39% | |
| 4. | 1,069,435 | $72,839,224 | 0.55% | |
| 5. | 1,052,241 | $71,668,134 | 0.07% |
News See All
Dividend Growth Stocks: 25 Aristocrats
Dividend aristocrats are companies that have raised their dividends every year for at least 25 years.
BofA Stays Positive on McCormick (MKC) Despite Weaker Q4 Results
BofA lowered its price target on McCormick & Company, Incorporated (NYSE:MKC) to $80 from $89 on January 23. However, the firm kept a Buy rating in place.
McCormick & Company, Incorporated (NYSE:MKC) Q4 2025 Earnings Call Transcript
McCormick & Company, Incorporated (NYSE:MKC) Q4 2025 Earnings Call Transcript January 22, 2026McCormick & Company, Incorporated misses on earnings expectations.
14 Stocks on Jim Cramer’s Game Plan for This Week
This market is kind of just meandering. It's erratic. It hates the banks one day, likes the banks another. Despises big tech one day, favors small tech the other.
Why Income Investors See McCormick & Company (MKC) as a Reliable Choice Among Food Dividend Stocks
McCormick & Company, Incorporated (NYSE:MKC), the company behind household names like Frank’s Red Hot and Cholula hot sauces, is facing a tricky market but seems to be handling it carefully.
14 Best Food Dividend Stocks To Buy According to Analysts
The US food industry continues to evolve as consumer habits shift and environmental challenges increase.
McCormick & Company, Incorporated (NYSE:MKC) Q3 2025 Earnings Call Transcript
McCormick & Company, Incorporated (NYSE:MKC) Q3 2025 Earnings Call Transcript October 7, 2025McCormick & Company, Incorporated beats earnings expectations.
Jim Cramer's Game Plan For This Week: 7 Stocks in Focus
“The president's been real quiet about stocks lately since the deal with Pfizer. That makes it look like the drug companies won't get hurt too badly by the president's plan to roll back drug prices.